BioXcel Therapeutics, Inc. (BTAI) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 206K | 256K | 98K | 120K | 168K | 366K | 214K | 1.1M | 582K | 376K | 341K | 457K | 206K | 238K | 137K | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 22.62% | -30.05% | -54.21% | -89.13% | -71.13% | -2.66% | -37.24% | 141.58% | 182.52% | 57.98% | 148.91% | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 341K | 32K | 11K | 107K | 14K | 832K | 1.17M | 62K | 158K | 714K | 512K | 26K | 9K | 9K | 11K | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 165.53% | 12.5% | 11.22% | 89.17% | 8.33% | 227.32% | 546.73% | 5.62% | 27.15% | 189.89% | 150.15% | 5.69% | 4.37% | 3.78% | 8.03% | - | - | - | - | - |
| Gross Profit | -135K | 224K | 87K | 13K | 154K | -466K | -956K | 1.04M | 424K | -338K | -171K | 431K | 197K | 229K | 126K | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | -65.53% | 87.5% | 88.78% | 10.83% | 91.67% | -127.32% | -446.73% | 94.38% | 72.85% | -89.89% | -50.15% | 94.31% | 95.63% | 96.22% | 91.97% | - | - | - | - | - |
| Gross Profit Growth % | -187.66% | 148.07% | 109.1% | -98.75% | -63.68% | -37.87% | -459.06% | 141.76% | 115.23% | -247.6% | -235.71% | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 9.98M | 10.51M | 14.12M | 15.87M | 10.25M | 10.03M | 14.34M | 18.34M | 24.35M | 19.54M | 48.13M | 52.84M | 51.4M | 53.12M | 39.12M | 36.29M | 31.48M | 26.13M | 26.81M | 27.61M |
| OpEx % of Revenue | 4846.12% | 4103.91% | 14409.18% | 13220.83% | 6102.98% | 2739.62% | 6699.53% | 1661.05% | 4184.36% | 5196.01% | 14113.2% | 11563.46% | 24949.03% | 22320.59% | 28551.82% | - | - | - | - | - |
| Selling, General & Admin | 7.19M | 3.81M | 5.38M | 5.61M | 5.7M | 4.09M | 7.68M | 9.45M | 13.22M | 9.6M | 24.34M | 25.87M | 23.59M | 20.66M | 17.05M | 18.38M | 12.92M | 13.61M | 14.88M | 14.1M |
| SG&A % of Revenue | 3490.78% | 1486.33% | 5490.82% | 4674.17% | 3392.26% | 1118.58% | 3590.19% | 855.98% | 2270.79% | 2553.99% | 7139% | 5661.27% | 11453.88% | 8682.35% | 12448.18% | - | - | - | - | - |
| Research & Development | 2.96M | 6.7M | 8.74M | 10.26M | 4.55M | 5.9M | 5.1M | 8.03M | 11.14M | 9.93M | 19.62M | 26.97M | 27.8M | 32.46M | 22.06M | 17.91M | 18.56M | 12.53M | 11.93M | 13.51M |
| R&D % of Revenue | 1434.47% | 2617.58% | 8918.37% | 8546.67% | 2710.71% | 1612.3% | 2383.64% | 727.54% | 1913.57% | 2642.02% | 5753.37% | 5902.19% | 13495.15% | 13638.24% | 16103.65% | - | - | - | - | - |
| Other Operating Expenses | -163K | 0 | 0 | 0 | 0 | 32K | 1000K | 856K | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.12M | -10.28M | -14.03M | -15.85M | -10.1M | -10.49M | -15.29M | -17.3M | -23.93M | -19.88M | -48.3M | -52.41M | -51.2M | -52.89M | -38.99M | -36.29M | -31.48M | -26.13M | -26.81M | -27.61M |
| Operating Margin % | -4911.65% | -4016.41% | -14320.41% | -13210% | -6011.31% | -2866.94% | -7146.26% | -1566.67% | -4111.51% | -5285.9% | -14163.34% | -11469.15% | -24853.4% | -22224.37% | -28459.85% | - | - | - | - | - |
| Operating Income Growth % | -0.19% | 2.01% | 8.23% | 8.35% | 57.8% | 47.21% | 68.34% | 67% | 53.26% | 62.42% | -23.87% | -44.44% | -62.64% | -102.42% | -45.42% | -31.42% | -19.34% | -23.86% | -8.25% | -28.82% |
| EBITDA | -10.06M | -10.21M | -13.96M | -15.78M | -10.02M | -10.42M | -15.22M | -17.22M | -23.85M | -19.8M | -48.22M | -52.26M | -51.12M | -52.81M | -38.91M | -36.2M | -31.4M | -26.05M | -26.73M | -27.53M |
| EBITDA Margin % | -4883.5% | -3987.5% | -14243.88% | -13147.5% | -5966.07% | -2845.9% | -7110.28% | -1559.69% | -4098.11% | -5265.16% | -14140.18% | -11435.67% | -24814.56% | -22190.34% | -28397.81% | - | - | - | - | - |
| EBITDA Growth % | -0.37% | 2% | 8.26% | 8.37% | 57.98% | 47.39% | 68.44% | 67.05% | 53.34% | 62.51% | -23.94% | -44.35% | -62.78% | -102.7% | -45.52% | -31.49% | -19.34% | -23.77% | -8.15% | -28.74% |
| D&A (Non-Cash Add-back) | 58K | 74K | 75K | 75K | 76K | 77K | 77K | 77K | 78K | 78K | 79K | 153K | 80K | 81K | 85K | 84K | 77K | 76K | 77K | 79K |
| EBIT | -10.12M | -8.15M | -26.54M | -14.96M | -3.26M | -6.83M | -9.86M | -4.6M | -23.18M | -18.82M | -47.23M | -50.26M | -49.43M | -50.79M | -38.1M | -36.08M | -31.46M | -26.12M | -26.81M | -27.6M |
| Net Interest Income | -3.99M | -4.08M | -4.14M | -3.99M | 1.05M | -3.66M | -3.17M | -3.03M | -2.66M | -2.49M | -2.18M | -1.64M | -1.35M | -1.43M | -2.88M | -1.38M | 8K | 6K | 1K | -6K |
| Interest Income | 211K | 321K | 236K | 230K | 1.05M | 368K | 616K | 671K | 947K | 946K | 1.07M | 1.62M | 2.02M | 1.49M | 823K | 204K | 15K | 12K | 12K | 10K |
| Interest Expense | 4.2M | 4.4M | 4.37M | 4.22M | 0 | 4.03M | 3.79M | 3.7M | 3.61M | 3.44M | 3.25M | 3.26M | 3.37M | 2.92M | 3.7M | 1.59M | 7K | 6K | 11K | 16K |
| Other Income/Expense | -2.57M | -2.26M | -16.88M | -3.33M | 2.85M | -366K | 1.64M | 9M | -2.86M | -2.38M | -2.19M | -1.1M | -1.6M | -1.91M | -2.81M | -1.38M | 8K | 6K | 1K | -6K |
| Pretax Income | -12.69M | -12.54M | -30.91M | -19.19M | -7.25M | -10.86M | -13.65M | -8.3M | -26.79M | -22.26M | -50.49M | -53.52M | -52.8M | -54.81M | -41.8M | -37.67M | -31.47M | -26.13M | -26.81M | -27.62M |
| Pretax Margin % | -6160.68% | -4900.39% | -31541.84% | -15989.17% | -4317.86% | -2966.94% | -6378.5% | -751.72% | -4603.26% | -5919.15% | -14805.28% | -11710.07% | -25629.13% | -23028.57% | -30514.6% | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -12.69M | -12.54M | -30.91M | -19.19M | -7.25M | -10.86M | -13.65M | -8.3M | -26.79M | -22.26M | -50.49M | -53.52M | -52.8M | -54.81M | -41.8M | -37.67M | -31.47M | -26.13M | -26.81M | -27.62M |
| Net Margin % | -6160.68% | -4900.39% | -31541.84% | -15989.17% | -4317.86% | -2966.94% | -6378.5% | -751.72% | -4603.26% | -5919.15% | -14805.28% | -11710.07% | -25629.13% | -23028.57% | -30514.6% | - | - | - | - | - |
| Net Income Growth % | -74.95% | -15.53% | -126.45% | -131.2% | 72.92% | 51.21% | 72.96% | 84.49% | 49.26% | 59.39% | -20.77% | -42.06% | -67.76% | -109.79% | -55.92% | -36.39% | -19.32% | -23.9% | -8.31% | -28.95% |
| Net Income (Continuing) | -12.69M | -12.54M | -30.91M | -19.19M | -7.25M | -10.86M | -13.65M | -8.3M | -26.79M | -22.26M | -50.49M | -53.52M | -52.8M | -54.81M | -41.8M | -37.67M | -31.47M | -26.13M | -26.81M | -27.62M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.04 | -1.03 | -2.18 | -2.45 | -1.50 | -3.57 | -5.15 | -3.30 | -13.89 | -12.09 | -27.60 | -29.34 | -29.52 | -31.24 | -23.87 | -21.53 | -18.00 | -14.94 | -15.34 | -17.70 |
| EPS Growth % | 30.67% | 71.15% | 57.67% | 25.76% | 89.2% | 70.47% | 81.34% | 88.75% | 52.95% | 61.3% | -15.63% | -36.27% | -64% | -109.1% | -55.61% | -21.64% | -4.59% | -7.95% | 10.71% | -4.8% |
| EPS (Basic) | -1.04 | -1.03 | -2.18 | -2.45 | -1.50 | -3.57 | -5.15 | -3.30 | -13.89 | -12.09 | -27.60 | -29.34 | -29.52 | -31.24 | -23.87 | -21.53 | -18.00 | -14.94 | -15.34 | -17.70 |
| Diluted Shares Outstanding | 12.21M | 12.21M | 14.2M | 7.84M | 4.83M | 3.04M | 2.65M | 2.52M | 1.93M | 1.84M | 1.83M | 1.82M | 1.79M | 1.75M | 1.75M | 1.75M | 1.75M | 1.75M | 1.75M | 1.56M |
| Basic Shares Outstanding | 12.21M | 12.21M | 14.2M | 7.84M | 4.83M | 3.04M | 2.65M | 2.52M | 1.93M | 1.84M | 1.83M | 1.82M | 1.79M | 1.75M | 1.75M | 1.75M | 1.75M | 1.75M | 1.75M | 1.56M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |